Claudia Omarini

1.3k total citations
54 papers, 777 citations indexed

About

Claudia Omarini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Claudia Omarini has authored 54 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 33 papers in Pulmonary and Respiratory Medicine and 23 papers in Cancer Research. Recurrent topics in Claudia Omarini's work include Advanced Breast Cancer Therapies (25 papers), HER2/EGFR in Cancer Research (19 papers) and Breast Cancer Treatment Studies (16 papers). Claudia Omarini is often cited by papers focused on Advanced Breast Cancer Therapies (25 papers), HER2/EGFR in Cancer Research (19 papers) and Breast Cancer Treatment Studies (16 papers). Claudia Omarini collaborates with scholars based in Italy, France and United Kingdom. Claudia Omarini's co-authors include Federico Piacentini, Massimo Dominici, Luca Moscetti, Guido Ficarra, Elena Barbieri, Pierfranco Conté, Valentina Guarneri, Maria Vittoria Dieci, Stefano Cascinu and Stefania Bettelli and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Claudia Omarini

47 papers receiving 765 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudia Omarini Italy 14 507 267 243 184 97 54 777
Mariana Brandão Belgium 16 468 0.9× 181 0.7× 200 0.8× 154 0.8× 102 1.1× 65 721
Felipe Ades Belgium 13 505 1.0× 348 1.3× 194 0.8× 212 1.2× 91 0.9× 32 836
Philippe Montcuquet France 16 581 1.1× 248 0.9× 332 1.4× 247 1.3× 66 0.7× 38 919
Concetta Elisa Onesti Italy 16 465 0.9× 255 1.0× 287 1.2× 334 1.8× 41 0.4× 58 937
Jenny Furlanetto Germany 16 553 1.1× 278 1.0× 215 0.9× 122 0.7× 66 0.7× 47 797
Cristian Villanueva France 16 706 1.4× 301 1.1× 508 2.1× 229 1.2× 77 0.8× 54 1.2k
Thomas J. Semrad United States 15 395 0.8× 162 0.6× 237 1.0× 257 1.4× 44 0.5× 51 890
Elisa Zanardi Italy 16 355 0.7× 170 0.6× 420 1.7× 177 1.0× 102 1.1× 56 785
C.J. Twelves United Kingdom 21 746 1.5× 219 0.8× 264 1.1× 89 0.5× 70 0.7× 55 987
Simon Spazzapan Italy 16 495 1.0× 244 0.9× 246 1.0× 77 0.4× 85 0.9× 60 776

Countries citing papers authored by Claudia Omarini

Since Specialization
Citations

This map shows the geographic impact of Claudia Omarini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Omarini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Omarini more than expected).

Fields of papers citing papers by Claudia Omarini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Omarini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Omarini. The network helps show where Claudia Omarini may publish in the future.

Co-authorship network of co-authors of Claudia Omarini

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Omarini. A scholar is included among the top collaborators of Claudia Omarini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Omarini. Claudia Omarini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farina, Alessandro, Federica Caggia, Monica Barbolini, et al.. (2025). Update on Pulmonary Toxicity Induced by New Breast Cancer Treatments. Breast Cancer Targets and Therapy. Volume 17. 53–66. 1 indexed citations
2.
3.
Bettelli, Stefania, Monica Barbolini, Luca Moscetti, et al.. (2024). Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients. International Journal of Molecular Sciences. 25(5). 2490–2490. 1 indexed citations
4.
Omarini, Claudia, Angela Toss, Ilenia Mastrolia, et al.. (2024). 417P EV derived miR-21 as a promising biomarker for early diagnosis and tumor activity in discrete BC subtypes: The Exobreast project. Annals of Oncology. 35. S395–S395. 1 indexed citations
5.
Cerma, Krisida, Federico Piacentini, Luca Moscetti, et al.. (2023). Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges. Biomedicines. 11(1). 109–109. 58 indexed citations
6.
Omarini, Claudia, Federico Piacentini, Isabella Sperduti, et al.. (2022). T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis. BMC Cancer. 22(1). 623–623. 6 indexed citations
7.
Piacentini, Federico, Claudia Omarini, Angela Toss, et al.. (2022). Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review. International Journal of Molecular Sciences. 23(13). 7079–7079. 9 indexed citations
8.
Omarini, Claudia, et al.. (2022). Ocular Toxicity in Breast Cancer Management: Manual for The Oncologist. Clinical Breast Cancer. 22(4). 289–299. 7 indexed citations
9.
Piacentini, Federico, Ilenia Mastrolia, Valentina Masciale, et al.. (2021). Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature. Cancers. 13(19). 4894–4894. 8 indexed citations
10.
Mastrolia, Ilenia, Claudia Omarini, Olivia Candini, et al.. (2021). The Role of Exosomes in Breast Cancer Diagnosis. Biomedicines. 9(3). 312–312. 31 indexed citations
11.
Omarini, Claudia, et al.. (2020). Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer. IRIS UNIMORE (University of Modena and Reggio Emilia). 10(7). 1–6. 1 indexed citations
12.
13.
Omarini, Claudia, Annarita Pecchi, Sara Balduzzi, et al.. (2019). <p>Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy</p>. Cancer Management and Research. Volume 11. 9563–9569. 20 indexed citations
14.
Omarini, Claudia, Stefania Bettelli, Cecilia Caprera, et al.. (2019). Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. Journal of Cancer Research and Clinical Oncology. 145(4). 821–828. 5 indexed citations
15.
Omarini, Claudia, Giorgia Guaitoli, Stefania Pipitone, et al.. (2018). Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going. Cancer Management and Research. Volume 10. 91–103. 56 indexed citations
16.
Guaitoli, Giorgia, Federico Piacentini, Claudia Omarini, et al.. (2018). Post-surgical pyoderma gangrenosum of the breast: needs for early diagnosis and right therapy. Breast Cancer. 26(4). 520–523. 7 indexed citations
17.
Omarini, Claudia, Stefania Bettelli, Shaniko Kaleci, et al.. (2018). Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus. BioMed Research International. 2018. 1–8. 8 indexed citations
18.
Omarini, Claudia, Stefania Bettelli, Cecilia Caprera, et al.. (2018). Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients. Cancer Biology & Therapy. 19(10). 879–886. 21 indexed citations
19.
Dieci, Maria Vittoria, Vassilena Tsvetkova, Enrico Orvieto, et al.. (2018). Immune characterization of breast cancer metastases: prognostic implications. Breast Cancer Research. 20(1). 62–62. 59 indexed citations
20.
Dieci, Maria Vittoria, Elena Barbieri, Stefania Bettelli, et al.. (2012). Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. Journal of Clinical Pathology. 65(6). 503–506. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariana Brandão Breakdown of academic impact, for papers by Felipe Ades Breakdown of academic impact, for papers by Philippe Montcuquet Breakdown of academic impact, for papers by Concetta Elisa Onesti Breakdown of academic impact, for papers by Jenny Furlanetto Breakdown of academic impact, for papers by Cristian Villanueva Breakdown of academic impact, for papers by Thomas J. Semrad Breakdown of academic impact, for papers by Elisa Zanardi Breakdown of academic impact, for papers by C.J. Twelves Breakdown of academic impact, for papers by Simon Spazzapan
Rankless by CCL
2026